数字化技术在阿尔茨海默病中的应用进展

doi:10.11958/20240039

天津医药 ›› 2024, Vol. 52 ›› Issue (10): 1106-1109.doi: 10.11958/20240039

数字化技术在阿尔茨海默病中的应用进展

冉龙飞¹(), 聂志强¹, 郭军辉¹^,²^,^△()

1 北大医疗海洋石油医院康复医学中心（邮编300452）
2 北京大学工学院

收稿日期:2024-01-08 修回日期:2024-04-16 出版日期:2024-10-15 发布日期:2024-10-14
通讯作者: △ E-mail：gjh8207@126.com
作者简介:冉龙飞（1990），男，主管康复治疗师，主要从事神经系统领域康复治疗研究。E-mail：564171630@qq.com
基金资助:
吴阶平医学基金会临床科研专项资助基金课题(320.6750.2023—15—12)

The application progress of digital technology in Alzheimer's disease

RAN Longfei¹(), NIE Zhiqiang¹, GUO Junhui¹^,²^,^△()

1 Rehabilitation Medicine Center of Peking University Medical Offshore Oil Hospital, Tianjin 300452, China
2 School of Engineering, Peking University

Received:2024-01-08 Revised:2024-04-16 Published:2024-10-15 Online:2024-10-14
Contact: △ E-mail：gjh8207@126.com

冉龙飞, 聂志强, 郭军辉. 数字化技术在阿尔茨海默病中的应用进展[J]. 天津医药, 2024, 52(10): 1106-1109.

RAN Longfei, NIE Zhiqiang, GUO Junhui. The application progress of digital technology in Alzheimer's disease[J]. Tianjin Medical Journal, 2024, 52(10): 1106-1109.

摘要/Abstract

摘要：

阿尔茨海默病（AD）是一类以认知功能下降、精神行为异常、日常生活能力下降为临床表现的神经系统退行性疾病。该疾病病因多样，发病隐匿，传统神经心理学量表评估费时、影像学检测敏感度低、药物研发进展缓慢。随着认知神经科学和数字技术的迅速发展，AI、虚拟现实等数字化技术越来越受到关注。该文综述近年来数字化技术在AD的预测、筛查、辅助诊断和治疗领域的临床研究，以及数字化技术在AD步态、精细运动、语音等多领域的进展与突破，为临床诊疗和进一步探索提供方向。

关键词: 阿尔茨海默病, AI, 虚拟现实, 数字化技术

Abstract:

Alzheimer's disease (AD) is a neurodegenerative disease characterized by clinical manifestations of cognitive decline, abnormal mental behavior and decreased ability to engage in daily activities. The etiology of this disease is diverse and the onset is insidious. Traditional neuropsychological assessments are time-consuming, imaging detection sensitivity is low, and drug development progress is slow. With the rapid development of cognitive neuroscience and digital technology, digital technologies such as artificial intelligence and virtual reality are receiving increasing attention. This article aims to review the clinical research on digital technology in the prediction, screening, auxiliary diagnosis and treatment of AD in recent years, as well as the progress and breakthroughs in multiple fields such as AD gait, fine motor and speech, providing a directions for clinical diagnosis and further exploration.

Key words: Alzheimer's disease, artificial intelligence, virtual reality, digital technology

中图分类号:

R749.16

参考文献 41

[1]	邵蕊, 李岱, 韩召利, 等. 基于老年综合评估的个体化康复训练对阿尔茨海默病患者认知功能、风险防范的影响[J]. 天津医药, 2021, 49(8):847-851.
	SHAO R, LI D, HAN Z L, et al. Effects of individualized rehabilitation training based on comprehensive geriatric assessment on cognitive function and risk prevention of patients with Alzheimer's disease[J]. Tianjin Med J, 2021, 49(8):847-851. doi:10.11958/20210643.
[2]	JIA L, QUAN M, FU Y, et al. Dementia in China: epidemiology,clinical management,and research advances[J]. Lancet Neurol, 2020, 19(1):81-92. doi:10.1016/S1474-4422(19)30290-X.
[3]	中国疾病预防控制中心慢性非传染性疾病控制中心, 国家卫生健康委统计信息中心. 中国死因监测数据集2021[M]. 北京: 中国科学技术出版社, 2022.
	Chronic Non communicable Disease Control Center of China Center for Disease Control and Prevention,Compiled by the Statistical Information Center of the National Health Commission. China Cause of Death Monitoring Dataset 2021[M]. Beijing: China Science and Technology Press, 2022.
[4]	田金洲, 解恒革, 王鲁宁, 等. 中国阿尔茨海默病痴呆诊疗指南(2020年版)[J]. 中华老年医学杂志, 2021, 40(3):269-283.
	TIAN J Z, XIE H G, WANG L N, et al. Chinese guideline for the diagnosis and treatment of Alzheimer's disease dementia(2020)[J]. Chinese Journal of Geriatrics, 2021, 40(3):269-283. doi:10.3760/cma.j.issn.0254-9026.2021.03.001.
[5]	万琪, 谢晔, 王蓉, 等. Gal-3参与阿尔茨海默病的机制研究进展[J]. 天津医药, 2022, 50(10):1115-1120.
	WAN Q, XIE Y, WANG R, et al. Research progress on the role of Gal-3 in Alzheimer's disease[J]. Tianjin Med J, 2022, 50(10):1115-1120. doi:10.11958/20220639.
[6]	YANG Y, LV C, LI H, et al. Community‑based model for dementia risk screening:the Beijing aging brain rejuvenation initiative(BABRI)brain health system[J]. J Am Med Dir Assoc, 2021, 22(7):1500-1506.e3. doi:10.1016/j.jamda.2020.12.024.
[7]	蒋平静, 谭小林, 于婷婷, 等. 基于电子化的痴呆与认知障碍早期识别筛查和诊断流程的探讨[J]. 阿尔茨海默病及相关病, 2021, 4(2):116-120.
	JIANG P J, TAN X L, YU T T, et al. Exploration of the early identification, screening,and diagnostic process for dementia and cognitive impairment based on electronicization[J]. Alzheimer's Disease and Related Diseases, 2021, 4(2):116-120. doi:10.3969/j.issn.2096-5516.2021.02.005.
[8]	CAMPOS-MAGDALENO M, LEIVA D, PEREIRO A X, et al. Changes in visual memory in mild cognitive impairment:a longitudinal study with CANTAB[J]. Psychol Med, 2021, 51(14):2465-2475. doi:10.1017/S0033291720001142.
[9]	SOLOMON T M, BARBONE J M, FEASTER H T, et al. Comparing the standard and electronic versions of the Alzheimer′s disease assessment scale-cognitive subscale:a validation study[J]. J Prev Alzheimers Dis, 2019, 6(4):237-241. doi:10.14283/jpad.2019.27.
[10]	JAMES C, RANSON J M, EVERSON R, et al. Performance of machine learning algorithms for predicting progression to dementia in memory clinic patients[J]. JAMA Netw Open, 2021, 4(12):e2136553. doi:10.1001/jamanetworkopen.2021.36553.
[11]	KLEIMAN M J, BARENHOLTZ E, GALVIN J E, et al. Screening for early-stage Alzheimer's disease using optimized feature sets and machine learning[J]. J Alzheimers Dis, 2021, 81(1):355-366. doi:10.3233/JAD-201377.
[12]	张双虎. 上海交通大学医学院附属仁济医院阿尔茨海默病有了数字认知筛查新方法[N]. 中国科学报,2023-09-13(004).
	ZHANG S H. Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital has developed a new digital cognitive screening method for Alzheimer's disease[N]. China Science Daily,2023-09-13(004). doi:10.28514/n.cnki.nkxsb.2023.002181.
[13]	FERNÁNDEZ MONTENEGRO J M, VILLARINI B, ANGELOPOULOU A, et al. A survey of Alzheimer's disease early diagnosis methods for cognitive assessment[J]. Sensors(Basel), 2020, 20(24):7292. doi:10.3390/s20247292.
[14]	MISKOWIAK K W, JESPERSEN A E, KESSING L V, et al. Cognition assessment in virtual reality:validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders[J]. J Psychiatr Res, 2021, 145:182-189. doi:10.1016/j.jpsychires.2021.12.002.
[15]	ZYGOURIS S, ILIADOU P, LAZAROU E, et al. Detection of mild cognitive impairment in an At-risk group of older adults:can a novel self-administered serious game-based screening test improve diagnostic accuracy?[J]. J Alzheimers Dis, 2020, 78(1):405-412. doi:10.3233/JAD-200880.
[16]	MAENG S, HONG J P, KIM W H, et al. Effects of virtual reality-based cognitive training in the elderly with and without mild cognitive impairment[J]. Psychiatry Investigation, 2021, 18(7):619-627. doi:10.30773/pi.2020.0446.
[17]	BRIMELOW R E, DAWE B, DISSANAYKA N. Preliminary research:virtual reality in residential aged care to reduce apathy and improve mood[J]. Cyberpsychol Behav Soc Netw, 2020, 23(3):165-170. doi:10.1089/cyber.2019.0286.
[18]	EL-SAPPAGH S, ALONSO J M, ISLAM S M R, et al. A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease[J]. Sci Rep, 2021, 11(1):2660. doi:10.1038/s41598-021-82098-3.
[19]	AL-NAAMI B, ABU OWIDA H, ABU MALLOUH M, et al. A new prototype of smart wearable monitoring system solution for Alzheimer's patients[J]. Med Devices(Auckl), 2021, 14:423-433. doi:10.2147/MDER.S339855.
[20]	UMEDA-KAMEYAMA Y, KAMEYAMA M, TANAKA T, et al. Screening of Alzheimer's disease by facial complexion using artificial intelligence[J]. Aging(Albany NY), 2021, 13(2):1765-1772. doi:10.18632/aging.202545.
[21]	HABCHI J, CHIA S, LIMBOCKER R, et al. Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease[J]. Proc Natl Acad Sci USA, 2017, 114(2):E200-E208. doi:10.1073/pnas.1615613114.
[22]	中国老年保健协会阿尔茨海默病分会. 阿尔茨海默病与帕金森病步态分析的中国专家共识[J]. 中华老年心脑血管病杂志, 2021, 23(11):1141-1145.
	Alzheimer's Disease Committee of Chinese Aging Well Association. Consensus of Chinese experts on gait analysis of Alzheimer's disease and Parkinson's disease[J]. Chinese Journal of Geriatric Cardiovascular Diseases, 2021, 23(11):1141-1145. doi:10.3969/j.issn.1009-0126.2021.11.006.
[23]	陶帅, 韩星, 孔丽文, 等. 基于步态的机器学习模型识别遗忘型轻度认知障碍和阿尔茨海默病[J]. 中国全科医学, 2022, 25(31):3857-3865.
	TAO S, HAN X, KONG L W, et al. Gait based machine learning model for identifying amnestic mild cognitive impairment and Alzheimer's disease[J]. Chinese Journal of General Medicine, 2022, 25(31):3857-3865.
[24]	OGAMA N, ENDO H, SATAKE S, et al. Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment[J]. J Cachexia Sarcopenia Muscle, 2021, 12(6):2045-2055. doi:10.1002/jcsm.12807.
[25]	KUO K, ZHANG Y R, CHEN S D, et al. Associations of grip strength,walking pace,and the risk of incident dementia:a prospective cohort study of 340212 participants[J]. Alzheimers Dement, 2023, 19(4):1415-1427. doi:10.1002/alz.12793.
[26]	FERNANDES C P, MONTALVO G, CALIGIURI M, et al. Handwriting changes in Alzheimer's disease:a systematic review[J]. J Alzheimers Dis, 2023, 96(1):1-11. doi:10.3233/JAD-230438.
[27]	QI H, ZHANG R, WEI Z, et al. A study of auxiliary screening for Alzheimer's disease based on handwriting characteristics[J]. Front Aging Neurosci, 2023, 15:1117250. doi:10.3389/fnagi.2023.1117250.
[28]	张剑红. 面向阿尔茨海默病早期检测的精确抓握感知运动融合研究[D]. 山东大学, 2023.
	ZHANG J H. Research on accurate grasp perception and motion fusion for early detection of Alzheimer's disease[D]. Shandong University, 2023. doi:10.27272/d.cnki.gshdu.2022.002729.
[29]	KACHOURI M, HOUMANI N, GARCIA-SALICETTI S, et al. A new scheme for the automatic assessment of Alzheimer's disease on a fine motor task with transfer learning[J]. Annu Int Conf IEEE Eng Med Biol Soc, 2021, 2021:3823-3829. doi:10.1109/EMBC46164.2021.9630539.
[30]	AHMED S, HAIGH A M, DE JAGER C A, et al. Connected speech as a marker of disease progression in autopsy-proven Alzheimer's disease[J]. Brain, 2013, 136(Pt 12):3727-3737. doi:10.1093/brain/awt269.
[31]	QIAO Y, XIE X Y, LIN G Z, et al. Computer-assisted speech analysis in mild cognitive impairment and Alzheimer's disease:a pilot study from Shanghai,China[J]. J Alzheimers Dis, 2020, 75(1):211-221. doi:10.3233/JAD-191056.
[32]	EYIGOZ E, MATHUR S, SANTAMARIA M, et al. Linguistic markers predict onset of Alzheimer's disease[J]. EClinical Medicine, 2020, 28:100583. doi:10.1016/j.eclinm.2020.100583.
[33]	郭爱华, 潘小平. 阿尔茨海默病的眼动跟踪研究[J]. 广东医学, 2021, 42(9):1132-1135.
	GUO A H, PAN X P. Eye tracking research on Alzheimer's disease[J]. Guangdong Medical Journal, 2021, 42(9):1132-1135. doi:10.13820/j.cnki.gdyx.20210042.
[34]	WILCOCKSON T D W, MARDANBEGI D, XIA B, et al. Abnormalities of saccadic eye movements in dementia due to Alzheimer's disease and mild cognitive impairment[J]. Aging(Albany NY), 2019, 11(15):5389-5398. doi:10.18632/aging.102118.
[35]	王立松, 宋佳琦, 吕洋. 基于眼动跟踪技术诊断阿尔茨海默病的Logistics回归模型的初步建立[J]. 陆军军医大学学报, 2023, 45(2):102-110.
	WANG L S, SONG J Q, LYU Y. Preliminary establishment of a logistic regression model for diagnosing Alzheimer's disease based on eye tracking technology[J]. Journal of Army Medical University, 2023, 45(2):102-110. doi:10.16016/j.2097-0927.202206109.
[36]	周鹏. 阿尔茨海默病评价仪[D]. 中国医科大学, 2022.
	ZHOU P. Alzheimer's disease evaluation instrument[D]. China Medical University, 2022. doi:10.27652/d.cnki.gzyku.2021.001042.
[37]	MATSUMOTO S, TSUNEMATSU T. Association between sleep,Alzheimer's,and Parkinson's disease[J]. Biology(Basel), 2021, 10(11):1127. doi:10.3390/biology10111127.
[38]	LIU Y S, WANG Y M, ZHA D J. Brain functional and structural changes in Alzheimer's disease with sleep disorders:a systematic review[J]. Front Psychiatry, 2021, 12:772068. doi:10.3389/fpsyt.2021.772068.
[39]	ROBERTS D M, SCHADE M M, MATHEW G M, et al. Detecting sleep using heart rate and motion data from multisensor consumer-grade wearables,relative to wrist actigraphy and polysomnography[J]. Sleep, 2020, 43(7):zsaa045. doi:10.1093/sleep/zsaa045.
[40]	HATHORN T, BYUN Y J, ROSEN R, et al. Clinical utility of smartphone applications for sleep physicians[J]. Sleep Breath, 2023, 27(6):2371-2377. doi:10.1007/s11325-023-02851-y.
[41]	GUMUSSU T C, DA POIAN G, CORTESI S, et al. Real-time detection of sleep arousals with a head-mounted accelerometer[J]. Annu Int Conf IEEE Eng Med Biol Soc, 2023, 2023:1-4. doi:10.1109/EMBC40787.2023.10340686.

数字化技术在阿尔茨海默病中的应用进展

The application progress of digital technology in Alzheimer's disease

引用本文

RichHTML

PDF (PC)

可视化

摘要/Abstract

使用本文

参考文献 41

相关文章 15

编辑推荐

Metrics

本文评价

[1]	慕静然, 骆延, 梁璇, 徐陶, 曾俊伟, 刘晓红. 补体系统激活参与阿尔茨海默病的研究进展[J]. 天津医药, 2024, 52(6): 663-668.
[2]	郑锴, 罗秀玲, 张玮豪, 刘宇利, 李玉明, 廖尚高. m6a甲基转移酶METTL3调控KAI1/CD82表达介导垂体神经内分泌肿瘤细胞生物学行为的机制研究[J]. 天津医药, 2023, 51(8): 785-790.
[3]	王翠, 杨畅, 金玉, 高蜜, 张雯, 王琼, 金海涛. 木犀草苷对阿尔茨海默病模型细胞凋亡和炎性因子表达的研究[J]. 天津医药, 2023, 51(7): 701-706.
[4]	陈俊, 郑锦豪, 陈家良, 陈博. 阿尔茨海默病患者血清GGT、CTHRC1表达水平检测及临床意义[J]. 天津医药, 2023, 51(2): 216-220.
[5]	孙绪高, 杨文超, 刘彦杰, 杨旭. 茶黄素调节Snail/Slug信号通路对口腔鳞癌细胞生物学行为的影响[J]. 天津医药, 2023, 51(11): 1164-1169.
[6]	刘畅, 范彩红, 刘佳, 刘亚珊, 张诗琪, 刘士铭, 申艳娜. Naa20通过抑制AIM2表达减轻脓毒症心肌损伤[J]. 天津医药, 2023, 51(10): 1065-1070.
[7]	韩楚仪, 张敬霞, 丛洪良. 碘对比剂诱发甲状腺功能减退的病因及临床特点研究进展[J]. 天津医药, 2022, 50(11): 1222-1226.
[8]	闫春晓, 李培越, 郑启秘, 邹晓, 李建波. 阿尔茨海默病患者血清中Apelin13和FKBP5的表达水平及临床意义[J]. 天津医药, 2022, 50(10): 1088-1092.
[9]	万琪, 谢晔, 王蓉, 骆延, 曾俊伟. Gal-3参与阿尔茨海默病的机制研究进展[J]. 天津医药, 2022, 50(10): 1115-1120.
[10]	张智鑫, 董冲, 孙超, 吴迪, 张威, 王凯, 高伟△. Kasai术对胆道闭锁患儿肝移植手术及预后的影响[J]. 天津医药, 2022, 50(1): 20-24.
[11]	葛军涛, 詹江华△. 胆道闭锁Kasai术后辅助治疗研究进展[J]. 天津医药, 2022, 50(1): 30-34.
[12]	邵蕊, 李岱, 韩召利, 张明义, 雷平. 基于老年综合评估的个体化康复训练对阿尔茨海默病患者认知功能、风险防范的影响[J]. 天津医药, 2021, 49(8): 847-851.
[13]	周丹 , 陈佩贤 , 杨树清 , 李巍 , 何添成 , 叶国麟 , 吴爱国 . Gail风险评估模型预测珠三角广佛地区女性散发性乳腺癌风险的适用性研究[J]. 天津医药, 2021, 49(8): 874-877.
[14]	葛亮, 苟庆云, 赵金凤, 高伟, 詹江华△. 肝脏CD4、CD8及CD68表达与Kasai术后胆管炎的关系研究[J]. 天津医药, 2020, 48(8): 720-725.
[15]	詹江华△，王立. 胆道闭锁围术期营养状况评价的临床意义[J]. 天津医药, 2019, 47(4): 342-345.